Browsing Category
Healthcare Industry News
2470 posts
Can Incannex Healthcare’s dual breakthrough in OSA and anxiety therapy lift IXHL shares in 2025?
Discover how Incannex Healthcare is converting major trial wins and smart capital moves into a stronger 2025 growth plan!
October 30, 2025
How the UK’s £55bn R&D funding plan aims to transform health, AI, and clean energy sectors
UK confirms £55B R&D funding through 2030 to power innovation in AI, health, and clean energy. Find out how this public investment could reshape UK industry.
October 30, 2025
Can Swiss Rockets’ new CoolMPS deal with MGI Tech make Europe a genomics powerhouse?
Find out how Swiss Rockets AG’s exclusive license for MGI Tech’s CoolMPS sequencing platform could redefine genomics and precision medicine worldwide.
October 29, 2025
Is QT Imaging (OTCQB: QTIH) turning its breast imaging hardware into an AI‑powered cloud platform through Intelerad?
QT Imaging partners with Intelerad to deploy cloud PACS for breast imaging and AI-powered research. Discover what this means for diagnostics and data workflows.
October 29, 2025
Is Lenskart the Nykaa of eyewear? What its IPO means for India’s D2C brand valuations in 2025
As Lenskart eyes a ₹70,000 crore IPO valuation, investors are asking if it can repeat Nykaa’s playbook for India’s D2C brands. Explore the real comparison.
October 29, 2025
Genedrive Plc (LSE: GDR) stock surges after Saudi Arabia signs MoU to pilot MT-RNR1 pharmacogenetic test kit
Genedrive Plc (LSE: GDR) surged 37% after Saudi Arabia agreed to pilot its MT-RNR1 test kit in neonatal care. Learn what this means for future adoption.
October 29, 2025
Medline files for Nasdaq IPO: Healthcare logistics leader prepares public comeback
Find out how Medline’s proposed Nasdaq listing could reshape the medical supply sector and mark a major IPO milestone for 2025 — read more now!
October 28, 2025
HHS grants VSee Health FedRAMP High ATO, clearing path for U.S. government telehealth adoption
Find out how VSee Health’s FedRAMP High ATO from HHS positions it to expand secure telehealth across U.S. federal agencies.
October 28, 2025
Anteris Technologies launches its pivotal trial phase for DurAVR THV, marking a regulatory turning point
Anteris Technologies launches the global PARADIGM pivotal trial of its DurAVR THV, challenging Edwards and Medtronic with biomimetic valve durability data—see how the race unfolds.
October 28, 2025
Inside Co-Diagnostics’ Saudi Arabia expansion: the CoMira JV bringing PCR manufacturing to the MENA region
Find out how Co-Diagnostics’ joint venture with Arabian Eagle is localizing its Co-Dx PCR platform through CoMira Diagnostics to transform Middle East testing access.
October 27, 2025